Replacing the β-cell mass in individuals with diabetes mellitus could restore normal metabolic control, and might become a therapy choice for these patients. This Review summarizes the options for regenerative therapy in pancreatic disease with focus on diabetes mellitus.
- Luc Bouwens
- Isabelle Houbracken
- Josue K. Mfopou